Overview
- POET completed a registered direct offering that brought in about $400 million by selling 19,047,620 shares paired with equal-count warrants priced at $21 per unit.
- Lumilens signed a joint development and supply agreement that includes a $50 million initial order and a framework that could top $500 million over five years if milestones are met.
- The financing package includes three-year warrants exercisable at $26.15, and Lumilens received a nine-year warrant to buy up to about 22.9 million POET shares at $8.25 tied to future purchase targets.
- CEO Suresh Venkatesan said POET is lifting wafer and optical engine capacity by roughly ten times, with engineering samples planned for late 2026 and a production ramp targeted for 2027.
- Management cautioned that revenue depends on successful development and qualification, a point underscored by POET’s roughly $1.1 million in trailing revenue and past order volatility after a Celestial AI deal was canceled by Marvell.